Description:

1. Active Substance: Doxorubicin
   • Natdox-LP contains the active ingredient doxorubicin hydrochloride. Doxorubicin is an anthracycline chemotherapy drug used in the treatment of various cancers.
2. Strength: 20 mg/10 ml Injection
   • Natdox-LP is available in the form of an injection, and each vial typically contains 20 mg of doxorubicin in 10 ml of solution. The strength represents the concentration of the active substance in each milliliter of the injection.
3. Medical Uses:
   • Doxorubicin is used in the treatment of a wide range of cancers, including breast cancer, lung cancer, ovarian cancer, and certain types of leukemia and lymphomas.
4. Mode of Action:
   • Doxorubicin works by intercalating into the DNA of cancer cells, disrupting DNA replication, and inhibiting the synthesis of RNA and proteins. It also generates free radicals that contribute to its cytotoxic effects on cancer cells.
5. Dosage and Administration:
   • The dosage of Natdox-LP is determined by a healthcare professional based on the type and stage of cancer being treated, the patient’s overall health, and other factors. It is administered through intravenous (IV) infusion in a healthcare setting.
6. Side Effects:
   • Common side effects of doxorubicin may include nausea, vomiting, hair loss, fatigue, and a lowered blood cell count (leading to an increased risk of infection and anemia). It can also have cardiac toxicity, and regular monitoring of heart function is essential.
7. Precautions:
   • Before using Natdox-LP, individuals should inform their healthcare provider about their medical history, existing medical conditions, and medications they are currently taking. Regular heart function tests (echocardiograms) and blood tests may be necessary during treatment.
8. Prescription Required:
   • Yes, Natdox-LP is a prescription medication. It should only be used under the supervision of a qualified oncologist or healthcare professional.
9. Duration of Treatment:
   • The duration of treatment with doxorubicin is determined by the healthcare provider based on the response to treatment and the specific cancer being treated.
10. Note:

• Doxorubicin is a potent chemotherapy drug with significant side effects, including potential effects on the heart. Its use requires close monitoring by healthcare professionals. Patients should communicate openly with their healthcare team about their experiences and any concerns during treatment.

It’s important to note that specific product information and medical guidance may vary, and the information provided here is a general description. Patients should refer to the product information leaflet provided with the medication and consult their healthcare provider for personalized advice.